Search results
Jump to navigation
Jump to search
Page title matches
- ...[coronary heart disease]], [[cerebrovascular disorder]]s, and [[peripheral vascular disease]]. ...Godwin J et al.| title=Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised31 KB (4,198 words) - 11:24, 23 July 2015
- 279 bytes (37 words) - 17:50, 14 May 2010
- In [[medicine]], '''peripheral vascular disease''' is a "pathological processes involving any one of the blood vessels in t935 bytes (116 words) - 11:56, 15 February 2009
- Auto-populated based on [[Special:WhatLinksHere/Vascular disease]]. Needs checking by a human.2 KB (210 words) - 09:32, 8 March 2010
- 195 bytes (28 words) - 05:19, 6 September 2009
- 101 bytes (13 words) - 09:13, 7 January 2009
- Auto-populated based on [[Special:WhatLinksHere/Peripheral vascular disease]]. Needs checking by a human. {{r|Vascular disease}}495 bytes (64 words) - 19:27, 11 January 2010
Page text matches
- Auto-populated based on [[Special:WhatLinksHere/Vascular disease]]. Needs checking by a human.2 KB (210 words) - 09:32, 8 March 2010
- Auto-populated based on [[Special:WhatLinksHere/Peripheral vascular disease]]. Needs checking by a human. {{r|Vascular disease}}495 bytes (64 words) - 19:27, 11 January 2010
- ...esigned to test chemoprevention with aspirin for the primary prevention of vascular disease.185 bytes (23 words) - 04:30, 11 December 2011
- {{r|Peripheral vascular disease}} {{r|Vascular disease}}968 bytes (121 words) - 15:42, 11 January 2010
- ===Vascular disease=== NSAIDs, especially [[diclofenac]], may cause recurrence of [[vascular disease]] among patients with prior [[myocardial infarction]]s.<ref name="pmid21551 KB (134 words) - 06:45, 27 May 2011
- {{r|Vascular disease}}854 bytes (105 words) - 11:08, 11 January 2010
- ...or simply '''Syndrome X''', is a "cluster of metabolic risk factors for [[vascular disease|cardiovascular disease]]s and [[Diabetes mellitus type 2|type 2 diabetes me629 bytes (71 words) - 11:35, 17 April 2009
- {{r|Vascular disease}}504 bytes (64 words) - 10:56, 11 January 2010
- {{r|Vascular disease}}516 bytes (66 words) - 17:20, 11 January 2010
- {{r|Vascular disease}}634 bytes (80 words) - 17:15, 11 January 2010
- In [[medicine]], '''peripheral vascular disease''' is a "pathological processes involving any one of the blood vessels in t935 bytes (116 words) - 11:56, 15 February 2009
- {{r|Peripheral vascular disease}}592 bytes (76 words) - 19:27, 11 January 2010
- {{r|Vascular disease}}348 bytes (42 words) - 23:54, 26 January 2011
- {{r|Vascular disease}}796 bytes (99 words) - 10:52, 11 January 2010
- {{r|Vascular disease}}720 bytes (96 words) - 19:58, 11 January 2010
- {{r|Vascular disease}}403 bytes (39 words) - 15:00, 27 May 2010
- {{r|Vascular disease}}992 bytes (122 words) - 11:06, 11 January 2010
- ...t of [[hypertension]], vasospasm, [[peripheral arterial disease|peripheral vascular disease]], [[shock]], and [[pheochromocytoma]]."<ref>{{MeSH}}</ref> They are also u2 KB (288 words) - 11:04, 11 June 2010
- {{r|Vascular disease}}1 KB (187 words) - 20:40, 11 January 2010
- ===Prediction vascular disease and mortality===3 KB (418 words) - 13:21, 15 February 2009
- {{r|Vascular disease}}487 bytes (61 words) - 10:58, 11 January 2010
- {{r|Vascular disease}}515 bytes (67 words) - 18:28, 11 January 2010
- {{r|Vascular disease}}1 KB (153 words) - 17:20, 11 January 2010
- {{r|Peripheral vascular disease}}481 bytes (62 words) - 21:28, 11 January 2010
- {{r|Vascular disease}}591 bytes (74 words) - 16:33, 11 January 2010
- {{r|Vascular disease}}686 bytes (93 words) - 10:58, 11 January 2010
- ...Kaptoge S, Ray KK et al.| title=Major lipids, apolipoproteins, and risk of vascular disease. | journal=JAMA | year= 2009 | volume= 302 | issue= 18 | pages= 1993-2000 |2 KB (299 words) - 01:31, 21 September 2010
- ===Vascular disease=== {{main|Vascular disease}}5 KB (688 words) - 21:20, 2 September 2011
- {{r|Vascular disease}}812 bytes (102 words) - 19:58, 11 January 2010
- {{r|Vascular disease}}2 KB (310 words) - 12:22, 18 April 2024
- {{r|Vascular disease}}3 KB (366 words) - 12:22, 18 April 2024
- ...arge enough for the presence of hyperuricemia to help in the prediction of vascular disease.<ref name="pmid15783260">{{cite journal |author=Wheeler JG, Juzwishin KD, E6 KB (819 words) - 22:44, 13 July 2010
- ...[[chemoprevention]] with [[aspirin]] for the [[primary prevention]] of [[vascular disease]].<ref name="pmid3125882">{{cite journal| author=Peto R, Gray R, Collins R,2 KB (242 words) - 21:10, 22 August 2010
- ...supplementation may actually be harmful when used for the prevention of [[vascular disease]].<ref name="pmid15537682">{{cite journal |author=Miller ER, Pastor-Barri1 KB (193 words) - 03:28, 6 January 2011
- ...beta-synthase]] and is a risk factor for [[coronary heart disease|coronary vascular disease]]."<ref>{{MeSH|Hyperhomocysteinemia}}</ref><ref name="OMIM - Hyperhomocyste ...fman JS, ''et al'' |title=Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomize8 KB (1,016 words) - 10:28, 2 November 2009
- ===Vascular disease prevention=== ...005758 |issn=}}</ref> and [[vitamin E]] (α-tocopherol) and reductions in [[vascular disease]].<ref name="pmid8479463">{{cite journal |author=Stampfer MJ, Hennekens CH,9 KB (1,254 words) - 01:42, 23 May 2009
- ...Ib-IIIa complex and inhibit platelet aggregation. They arp used to treat [[vascular disease]]s.2 KB (291 words) - 21:55, 14 February 2010
- ...n to have numerous healthful benefits. It has been shown to reduce cardio-vascular disease3 KB (407 words) - 08:24, 28 October 2009
- Estrogen replacement therapy was at one time thought to reduce death from [[vascular disease]] due to the findings of the Nurse' Health Study.<ref name="pmid1870648">{{5 KB (693 words) - 22:47, 19 October 2011
- ...mmon cause of eosinophilia in the United States), malignancy, and collagen-vascular disease.3 KB (322 words) - 11:33, 6 August 2010
- ...h-risk diabetes|| "Telmisartan was equivalent to ramipril in patients with vascular disease or high-risk diabetes and was associated with less angioedema. The combinat15 KB (2,041 words) - 22:49, 6 June 2012
- Originally thought to reduce vascular disease<ref name="pmid1443971">American College of Physicians. 1992 http://pubmed.g7 KB (894 words) - 05:24, 10 September 2010
- ===Vascular disease=== NSAIDs, especially [[diclofenac]], may cause recurrence of [[vascular disease]] among patients with prior [[myocardial infarction]]s.<ref name="pmid2155514 KB (1,835 words) - 06:45, 27 May 2011
- ...ordestgaard BG |title=Genetically elevated C-reactive protein and ischemic vascular disease |journal=N. Engl. J. Med. |volume=359 |issue=18 |pages=1897–908 |year=20018 KB (2,514 words) - 01:24, 1 June 2012
- | journal =The British Journal of Diabetes and Vascular Disease4 KB (480 words) - 03:50, 26 April 2012
- ...psychological]] diseases, [[antiviral drug]]s, [[erectile dysfunction]], [[vascular disease]], [[steroid]]-related diseases, [[migraine headache]]s, [[sleep disorder]]8 KB (985 words) - 19:04, 4 September 2013
- ...psychological]] diseases, [[antiviral drug]]s, [[erectile dysfunction]], [[vascular disease]], [[steroid]]-related diseases, [[migraine headache]]s, [[sleep disorder]]8 KB (984 words) - 19:05, 4 September 2013
- ...[coronary heart disease]], [[cerebrovascular disorder]]s, and [[peripheral vascular disease]]. ...Godwin J et al.| title=Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised31 KB (4,198 words) - 11:24, 23 July 2015
- ...psychiatric illnesses, neoplasms, infections, posttraumatic sequelae, and vascular disease. Causes of dementia can be identified or eliminated by history and clinical11 KB (1,654 words) - 09:12, 31 August 2010
- ...supplementation may actually be harmful when used for the prevention of [[vascular disease]].<ref name="pmid15537682">{{cite journal |author=Miller ER, Pastor-Barriu13 KB (1,824 words) - 20:28, 25 June 2012